665PNRF2 activation via PI3K/AKT/mTOR/RPS6 causes resistance to anti-HER2 agents among HER2 amplified gastric cancer
Gambardella, V, Gimeno-Valiente, F, Tarazona, N, Fleitas Kanonnikoff, T, Tolosa, P, Belda Moscardò, M, Garcia-Mico, B, Huerta, M, Roselló, S, Roda, D, Cervantes, A, Castillo, JVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.049
Date:
October, 2018
File:
PDF, 76 KB
2018